http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-2925862-A1

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_6c4fdb8c9e4f1a1676cf97b8a47c8e95
classificationCPCAdditional http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N2501-998
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N2500-90
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N2533-54
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N2501-395
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N2500-38
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N2500-98
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N2501-33
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N2501-11
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N2501-115
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N2501-15
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N2500-12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N2501-135
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N2501-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N2500-25
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N5-0667
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N5-0775
filingDate 2013-10-30-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_aec2d9ccee11955d9fcc1616bbe44bdd
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_178fbdb915630f275731805e0435e085
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_f06d466d37f2db22bee5d837e7e557a6
publicationDate 2015-10-07-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber EP-2925862-A1
titleOfInvention Serum-free medium for human mesenchymal stem cells
abstract A highly effective serum-free growth medium, especially adapted for human MSCs and their subtypes, comprising, dissolved and/or suspended in a basis cell growth medium, at least five components selected from: human transferrin, human insulin, selenium or a salt thereof, human thyreoglobulin, human albumin, ascorbic acid or a salt thereof, pyruvic acid or a salt thereof; one or more human growth factors, and/or one or more additives selected from: a strontium salt, vitamin D, rosiglitazone, a prostaglandin, a BMP protein.
priorityDate 2012-11-30-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2010015710-A1
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID135398631
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID54676860
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID7168051
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID77999
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226393724
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID129139453
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226421170
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226396964
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226397425
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID54679073

Total number of triples: 38.